SAB Biotherapeutics Inc (SABS)
4.03
+0.01
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
SAB Biotherapeutics 1 Year Total Returns (Daily): -53.68% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | -53.68% |
| May 02, 2024 | -51.97% |
| May 01, 2024 | -53.41% |
| April 30, 2024 | -52.24% |
| April 29, 2024 | -53.36% |
| April 26, 2024 | -41.10% |
| April 25, 2024 | -48.26% |
| April 24, 2024 | -40.31% |
| April 23, 2024 | -44.81% |
| April 22, 2024 | -44.43% |
| April 19, 2024 | -55.77% |
| April 18, 2024 | -59.08% |
| April 17, 2024 | -40.26% |
| April 16, 2024 | -32.74% |
| April 15, 2024 | -36.46% |
| April 12, 2024 | 23.03% |
| April 11, 2024 | 10.71% |
| April 10, 2024 | 10.71% |
| April 09, 2024 | 8.62% |
| April 08, 2024 | 8.62% |
| April 05, 2024 | -1.36% |
| April 04, 2024 | -8.72% |
| April 03, 2024 | -4.09% |
| April 02, 2024 | 2.27% |
| April 01, 2024 | -2.50% |
| Date | Value |
|---|---|
| March 28, 2024 | 0.87% |
| March 27, 2024 | -9.96% |
| March 26, 2024 | -16.25% |
| March 25, 2024 | -14.64% |
| March 22, 2024 | -4.31% |
| March 21, 2024 | -9.74% |
| March 20, 2024 | -7.90% |
| March 19, 2024 | -5.99% |
| March 18, 2024 | 5.76% |
| March 15, 2024 | 8.24% |
| March 14, 2024 | 12.15% |
| March 13, 2024 | 2.10% |
| March 12, 2024 | 5.24% |
| March 11, 2024 | -1.40% |
| March 08, 2024 | -10.58% |
| March 07, 2024 | -13.36% |
| March 06, 2024 | -14.69% |
| March 05, 2024 | -25.52% |
| March 04, 2024 | -35.07% |
| March 01, 2024 | -32.61% |
| February 29, 2024 | -31.38% |
| February 28, 2024 | -35.08% |
| February 27, 2024 | -27.54% |
| February 26, 2024 | -22.03% |
| February 23, 2024 | -28.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.87%
Minimum
Dec 28 2022
29.85%
Maximum
Oct 24 2023
-55.11%
Average
-70.82%
Median
Apr 07 2022
1 Year Total Returns (Daily) Benchmarks
| CEL-SCI Corp | -27.23% |
| AIM ImmunoTech Inc | -15.65% |
| IGC Pharma Inc | 53.98% |
| NovaBay Pharmaceuticals Inc | -90.79% |
| Protalix BioTherapeutics Inc | -63.81% |